FOXP3 and autoimmune hepatitis: Accumulating evidence suggests that increasing the population of Treg cells can ameliorate AIH [33,34,35], indicating that the delivery of Foxp3 via AAV to enhance Treg proportions may represent a promising therapeutic strategy for AIH.